Difficulty: Medium
Average Score: 81%
Practice
Which of the following antienzymes is a monoamine oxidase (MAO) inhibitor?
Correct answer
B
Rationale
In the context of advanced pharmacology across the lifespan, understanding the mechanism of action of different drug classes is crucial. In this question, the correct answer is B) Selegiline, which is a monoamine oxidase (MAO) inhibitor. MAO inhibitors are commonly used in the treatment of depression and Parkinson's disease by preventing the breakdown of monoamine neurotransmitters in the brain.
Physostigmine (option A) is an acetylcholinesterase inhibitor used for the treatment of anticholinergic toxicity and glaucoma. Acetazolamide (option C) is a carbonic anhydrase inhibitor primarily used as a diuretic and in the management of glaucoma and altitude sickness. Disulfiram (option D) is an alcohol-sensitizing agent used in the treatment of alcohol dependence by inhibiting aldehyde dehydrogenase.
Educationally, knowing the specific drug classes and their mechanisms of action is essential for pharmacology students and healthcare professionals to make informed decisions regarding drug therapy. Understanding the differences between these medications can prevent medication errors and ensure optimal patient outcomes. Remembering that Selegiline is an MAO inhibitor can aid in selecting appropriate treatment options for patients with conditions where MAO inhibition is beneficial.
Physostigmine (option A) is an acetylcholinesterase inhibitor used for the treatment of anticholinergic toxicity and glaucoma. Acetazolamide (option C) is a carbonic anhydrase inhibitor primarily used as a diuretic and in the management of glaucoma and altitude sickness. Disulfiram (option D) is an alcohol-sensitizing agent used in the treatment of alcohol dependence by inhibiting aldehyde dehydrogenase.
Educationally, knowing the specific drug classes and their mechanisms of action is essential for pharmacology students and healthcare professionals to make informed decisions regarding drug therapy. Understanding the differences between these medications can prevent medication errors and ensure optimal patient outcomes. Remembering that Selegiline is an MAO inhibitor can aid in selecting appropriate treatment options for patients with conditions where MAO inhibition is beneficial.